Magda Marcatti

The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemia

Alessandro Bruno, Francesca Lorentino, Matteo G. Carrabba, Sara Mastaglio et autres

it (code pays fourni par la source)

Cytarabine as a salvage mobilization strategy after failure of cyclophosphamide-based stem cell collection for Daratumumab-treated multiple myeloma patients

Tommaso Perini, Alessia Orsini, Francesca Farina, Valeria Ferla et autres

it (code pays fourni par la source)

Editorial Expression of Concern: Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers

Francesca Cottini, Teru Hideshima, Chunxiao Xu, Martin Sattler et autres

us, it (code pays fourni par la source)

Challenging features of left ventricular wall thickening in a young patient with multiple myeloma and shock: when magnetic resonance imaging makes the difference—a case report

Carmine Galdieri, Stefania Sacchi, Magda Marcatti, Silvia Ajello et autres

it (code pays fourni par la source)

Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients

Fortunato Morabito, Enrica Antonia Martino, Mónica Galli, Massimo Offidani et autres

it (code pays fourni par la source)

VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation

Francesco Autore, Daniele Mannina, Federica Lessi, Eugenio Galli et autres

it (code pays fourni par la source)

Author response for "VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation"

Francesco Autore, Daniele Mannina, Federica Lessi, Eugenio Galli et autres

Author response for "VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation"

Francesco Autore, Daniele Mannina, Federica Lessi, Eugenio Galli et autres

Impact of Respiratory Syncytial Virus (RSV) on adult haematology oncology patients

Francesca Farina, Daniele Sannipoli, Elisa Diral, Sara Mastaglio et autres

it (code pays fourni par la source)

Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions

Valeria Ferla, Francesca Farina, Tommaso Perini, Magda Marcatti et autres

it (code pays fourni par la source)

A real‐world retrospective–prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience

Anna Furlan, Michele Cea, Laura Pavan, Mónica Galli et autres

it, ua (code pays fourni par la source)

Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients

Simona Piemontese, Maria Teresa Lupo Stanghellini, Federica Sorà, Simona Sica et autres

it (code pays fourni par la source)